Documents|Extraction of 8-oxodG from Biological Fluids Using ISOLUTE ENV+
Extraction of 8-oxodG from Biological Fluids Using ISOLUTE ENV+
This application note describes a SPE-UHPLC-MS/MS procedure for the analysis of 8-oxodG, a biomarker of oxidative stress, from various human biofluids using ISOLUTE ENV+ solid phase extraction columns. Oxidative stress is the imbalance between the production of reactive oxygen species (ROS) and the body's ability to eliminate them, in favour of the former. ROS have been linked with development of numerous diseases including Parkinson's and Alzheimer's and have also been associated with fertility problems. 8-Oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) is one of the mutagenic nucleobase modifications produced in DNA and the 2'deoxyribonucleotide pool, by the reaction of ROS. Measurement of 8-oxodG in biological fluids can provide a useful indicator of oxidative stress.
8-oxodG, sample prep, ENV+, urine, biological fluids, biomarker, oxidative stress, nucleotide,
DownloadE-mail a CopyExtraction of 8-oxodG from Biological Fluids Using ISOLUTE ENV+
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs appr. 700 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.